Delivery Order SPE2DB25D3404-SPE2DB25FUNGG
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$7.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide GARDASIL 9 syringes (0.5 ML) under a Firm Fixed Price Delivery Order contract. The award has a ceiling value of $4,874.64 and an ultimate completion date of February 25, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GARDASIL 9 syringes. The contract has a ceiling value of $6,026.44 and a completion date of March 5, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GARDASIL 9 syringes. The contract has a ceiling value of $17,871.64 and a period of performance through March 12, 2025. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $11,675.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with an ultimate completion date of April 17, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a $999,999,999 Indefinite Delivery Contract (IDC) for the supply of GARDASIL 9 syringes. The contract has a firm fixed price and a ceiling value of $11,147.96 with a performance period through March 2025. This order is part of the DLA Troop Support Medical IDC, which provides a broad range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of GARDASIL 9 syringes (0.5 mL). The contract, valued at $2,503.60, is a firm fixed-price delivery order with a completion date of June 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $1,889.05 and a completion date of April 4, 2025. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,828.06, is a delivery order for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a period of performance through April 11, 2025 and is a firm fixed-price contract. The contract is not set-aside and was awarded as part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,540.68, is for the delivery of GARDASIL 9 syringes (0.5 mL) and has a completion date of February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves...
This federal contract award is for the delivery of GARDASIL 9 SYRINGE 0.5ML to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $14,162.95 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation. This contract award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...